Gene mapping aims to speed up access to experimental cancer drugs
NCT ID NCT04510766
First seen Nov 18, 2025 · Last updated Apr 24, 2026 · Updated 20 times
Summary
This study looks at the genetic makeup of tumors from 40 adults with advanced solid tumors or lymphoma. The goal is to use this information to help more patients join early phase clinical trials that may target their specific cancer mutations. No new treatment is given; the study only collects and analyzes existing tumor samples and health data.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Oncology Institute of Southern Switzerland
RECRUITINGBellinzona, 6500, Switzerland
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.